INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,346,237 | +38.7% | 126,550 | -17.2% | 0.01% | +50.0% |
| Q2 2023 | $1,691,074 | -13.3% | 152,900 | +5.2% | 0.01% | -27.3% |
| Q1 2023 | $1,951,258 | +10.9% | 145,291 | +2.2% | 0.01% | +10.0% |
| Q4 2022 | $1,759,299 | -7.4% | 142,223 | +4.4% | 0.01% | -16.7% |
| Q3 2022 | $1,900,000 | +40.3% | 136,193 | +38.9% | 0.01% | +50.0% |
| Q2 2022 | $1,354,000 | -22.1% | 98,036 | -8.2% | 0.01% | -11.1% |
| Q1 2022 | $1,738,000 | -9.3% | 106,843 | -9.2% | 0.01% | 0.0% |
| Q4 2021 | $1,916,000 | +9.2% | 117,629 | -0.4% | 0.01% | 0.0% |
| Q3 2021 | $1,754,000 | -26.8% | 118,095 | -1.6% | 0.01% | -25.0% |
| Q2 2021 | $2,396,000 | -6.5% | 119,996 | +8.1% | 0.01% | -14.3% |
| Q1 2021 | $2,563,000 | +282.0% | 111,045 | +2482.4% | 0.01% | +180.0% |
| Q4 2014 | $671,000 | – | 4,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |